US files long-awaited charges in alleged generic drug cartel

After a federal generic drug price-fixing investigation percolated for years behind the government’s enforcement curtain, US antitrust enforcers today accused two pharmaceutical executives of conspiring with rivals to rig the price of two generic drugs.

Unlock unlimited access to all Global Competition Review content